TuHURA Biosciences Inc (HURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $88.58M
Last updated: Nov 17, 2026 at 11:06 AM ET
TuHURA Biosciences Inc (HURA) Stock Forecast
Analysts expect TuHURA Biosciences (HURA) to earn -$0.53 per share in the fiscal year ending Dec 31, 2026. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.50, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 50.0% |
| Buy | 2 | 50.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Dec 31, 2026
- -$0.53
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.61
- EPS consensus, revenue $13.54M
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.53 | -$0.55 to -$0.51 | 2 | N/A | N/A | 5 |
| Dec 31, 2027 | -$0.61 | -$0.61 to -$0.60 | 2 | $13.54M | N/A | 5 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.14 | -$0.16 to -$0.13 | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.53 | -$0.53 | -$0.53 | -$0.53 | -$0.50 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.61 | -$0.61 | -$0.61 | -$0.61 | N/A | N/A |
Frequently Asked Questions About HURA
What is the HURA stock forecast?
Consensus analyst estimates put TuHURA Biosciences's EPS at -$0.53 for the fiscal year ending Dec 31, 2026. The consensus rating from 4 analysts is Buy.
How do analysts rate HURA stock?
Of 4 analysts covering TuHURA Biosciences, 2 rate it Strong Buy, 2 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from HURA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.53, with estimates from -$0.55 to -$0.51 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.61, with estimates from -$0.61 to -$0.60 from 2 analysts.
What revenue do analysts expect from TuHURA Biosciences next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $13.54M.
How many analysts cover HURA?
4 analysts rate TuHURA Biosciences stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
HURA pages: Overview, Earnings, Forecast, Financials, Competitors